Amp Capital Investors LTD Exelixis, Inc. Transaction History

Amp Capital Investors LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$14.46 - $21.8 $179,014 - $269,884	-12,380 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$15.15 - $18.89 $187,557 - $233,858	12,380 New	12,380 $219,000
Q2 2018 Aug 13, 2018	SELL	$18.56 - $22.45 $495,551 - $599,415	-26,700 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $374,335 - $538,941	16,900 Added 172.45%	26,700 $597,000
Q4 2017 Feb 14, 2018	SELL	$24.23 - $30.93 $358,604 - $457,764	-14,800 Reduced 60.16%	9,800 $298,000
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $574,410 - $719,304	24,600	24,600 $596,000

565

252M

1.45M

1.13M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.